Europe Glioma Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Glioma Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Glioma Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Glioma Treatment Market Regional Analysis

6.2 Europe Glioma Treatment Market Revenue 2020-2030 (US$ Million)

6.3 Europe Glioma Treatment Market Forecast Analysis

7. Europe Glioma Treatment Market Analysis – by Disease

7.1 Astrocytoma

7.1.1 Overview
7.1.2 Astrocytoma: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Oligoastrocytoma

7.2.1 Overview
7.2.2 Oligoastrocytoma: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Oligodendroglioma

7.3.1 Overview
7.3.2 Oligodendroglioma: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Glioma Treatment Market Analysis – by Treatment Type

8.1 Surgery

8.1.1 Overview
8.1.2 Surgery: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Chemotherapy

8.2.1 Overview
8.2.2 Chemotherapy: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Radiation Therapy

8.3.1 Overview
8.3.2 Radiation Therapy: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Glioma Treatment Market Analysis – by Grade

9.1 Low Grade

9.1.1 Overview
9.1.2 Low Grade: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 High Grade

9.2.1 Overview
9.2.2 High Grade: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Glioma Treatment Market Analysis – by End User

10.1 Hospital & Clinics

10.1.1 Overview
10.1.2 Hospital & Clinics: Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Ambulatory Surgical Center

10.2.1 Overview
10.2.2 Ambulatory Surgical Center : Europe Glioma Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Glioma Treatment Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Glioma Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Glioma Treatment Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.1.2 UK: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.1.3 UK: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.1.4 UK: Europe Glioma Treatment Market Breakdown, by End User

11.2.1.2 Germany: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.2.2 Germany: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.2.3 Germany: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.2.4 Germany: Europe Glioma Treatment Market Breakdown, by End User

11.2.1.3 France: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.3.2 France: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.3.3 France: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.3.4 France: Europe Glioma Treatment Market Breakdown, by End User

11.2.1.4 Russia: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.4.2 Russia: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.4.3 Russia: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.4.4 Russia: Europe Glioma Treatment Market Breakdown, by End User

11.2.1.5 Italy: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.5.2 Italy: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.5.3 Italy: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.5.4 Italy: Europe Glioma Treatment Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Glioma Treatment Market Breakdown, by Disease
11.2.1.6.2 Rest of Europe: Europe Glioma Treatment Market Breakdown, by Treatment Type
11.2.1.6.3 Rest of Europe: Europe Glioma Treatment Market Breakdown, by Grade
11.2.1.6.4 Rest of Europe: Europe Glioma Treatment Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Amgen Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Amneal Pharmaceuticals Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Biocon Ltd

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 F. Hoffmann-La Roche Ltd

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Karyopharm Therapeutics Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Merck & Co Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Pfizer Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sun Pharmaceutical Industries Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Teva Pharmaceutical Industries Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Glioma Treatment Market

Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)